tiprankstipranks
Trending News
More News >
Xaar PLC (GB:XAR)
LSE:XAR

Xaar plc (XAR) AI Stock Analysis

Compare
7 Followers

Top Page

GB:XAR

Xaar plc

(LSE:XAR)

Select Model
Select Model
Select Model
Neutral 56 (OpenAI - 5.2)
Rating:56Neutral
Price Target:
111.00p
▲(6.73% Upside)
Xaar plc's overall stock score reflects significant challenges in financial performance, with declining revenue and profitability. However, the company's strong equity position and recent positive corporate events, including director share purchases and a positive outlook, provide some optimism. Technical analysis suggests a neutral trend, while valuation remains unattractive due to negative earnings.
Positive Factors
Balance sheet strength
A very high equity ratio and minimal leverage give Xaar durable financial resilience. Low debt reduces refinancing risk and preserves flexibility to invest in R&D and capex, helping the company weather industry cycles and support long-term product development.
Free cash flow improvement
The shift to positive free cash flow provides an enduring source of internal funding for product development, working capital and strategic partnerships. Consistent FCF reduces dependence on external financing and supports sustainable execution of growth initiatives.
Durable business model
Xaar's specialized piezoelectric printheads, recurring consumables and maintenance revenues, plus OEM partnerships, create recurring income and product stickiness. Diverse end-markets (ceramics, labels, packaging) support structural demand and competitive positioning.
Negative Factors
Declining revenue
Sustained top-line decline undermines scale and operating leverage. Continued revenue contraction makes fixed costs harder to cover, constrains reinvestment for R&D or capex, and lengthens the time horizon to restore margins and competitiveness.
Negative operating profitability
Persistently negative EBIT and net margins indicate the business cannot currently convert sales into sustainable profits. This erodes retained earnings, limits cash available for strategic investment, and raises concerns about structural cost competitiveness.
Earnings deterioration
A severe EPS contraction signals pronounced earnings volatility and deterioration. That reduces management flexibility, increases vulnerability to shocks, and may force restructuring or external funding choices that could impair long-term return prospects if not reversed.

Xaar plc (XAR) vs. iShares MSCI United Kingdom ETF (EWC)

Xaar plc Business Overview & Revenue Model

Company DescriptionXaar plc designs, develops, manufactures, markets, and sells printheads and associated products in Europe, the Middle East, Africa, Asia, and the Americas. It operates through three segments: Printhead, Product Print Systems, and Digital Imaging segments. The company offers print head products; digital imaging solutions, comprising digital inkjet label presses and digital pathology scanners; industrial ink management and supply systems for digital inkjet; industrial printing machines; and system components, such as ink system test kit, print manager, hydra ink supply system, midas ink supply system, inkjet development system, head personality card 3 and 6, and 2001+ head personality card. Its products are used in 3D printing, ceramic tile decoration, coding and marking, decorative laminates, direct-to-shape, functional fluid deposition, glass printing, graphics, primary labels, packaging, and product printing. The company was founded in 1990 and is headquartered in Cambridge, the United Kingdom.
How the Company Makes MoneyXaar generates revenue primarily through the sale of its inkjet printheads and associated products, which are sold to manufacturers and businesses in various sectors. Key revenue streams include direct sales of printheads, components, and systems, as well as recurring income from consumables such as inks and maintenance services. The company also engages in partnerships with equipment manufacturers and technology providers to integrate its printheads into broader printing solutions, which can lead to additional revenue opportunities. Xaar's focus on research and development enables it to maintain a competitive edge, continually innovating and expanding its product offerings to meet evolving market demands.

Xaar plc Financial Statement Overview

Summary
Xaar plc faces challenges with declining revenue and profitability, as highlighted by negative profit margins and a negative Return on Equity. However, the company maintains a strong equity position with low leverage, which provides financial stability. The improvement in Free Cash Flow is a positive sign, but overall performance is hindered by ongoing operational inefficiencies and profitability issues.
Income Statement
40
Negative
Xaar plc has experienced declining revenue over the past year, with a Revenue Growth Rate of -13.03%. The Gross Profit Margin stands at 36.18%, which is a decrease from the previous year. The company is struggling with profitability, as evidenced by negative Net Profit Margin and EBIT Margin values of -17.41% and -18.01%, respectively. EBITDA Margin is slightly better at -7.20%, but still negative, indicating challenges in covering operating expenses.
Balance Sheet
65
Positive
The balance sheet shows a solid Equity Ratio of 77.06%, suggesting a strong reliance on equity financing. However, the Return on Equity is negative at -17.19%, reflecting net losses. The Debt-to-Equity Ratio is low at 0.10, indicating low leverage and a conservative capital structure. Despite these strengths, the company’s profitability issues remain a concern.
Cash Flow
55
Neutral
Xaar plc's Free Cash Flow has improved from a negative position last year to a positive Free Cash Flow of 5.58 million. The Operating Cash Flow to Net Income Ratio stands at -0.62, showing a disconnect between reported earnings and cash generation. The Free Cash Flow to Net Income Ratio is favorable at -0.52, indicating some level of efficiency in converting earnings into cash.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue59.98M61.41M70.61M72.78M59.25M47.98M
Gross Profit21.18M22.22M26.89M28.64M20.19M13.01M
EBITDA-6.43M-4.42M3.45M6.03M5.90M288.00K
Net Income-11.19M-10.69M-2.17M1.63M16.22M-11.69M
Balance Sheet
Total Assets74.99M80.69M97.26M102.44M103.94M73.54M
Cash, Cash Equivalents and Short-Term Investments6.79M10.56M9.46M9.06M25.05M18.12M
Total Debt5.34M6.49M10.10M9.21M9.19M2.58M
Total Liabilities16.36M18.50M25.43M30.67M35.14M17.38M
Stockholders Equity58.62M62.18M71.83M71.77M68.80M52.39M
Cash Flow
Free Cash Flow589.00K5.58M-2.39M-10.89M-3.97M-3.90M
Operating Cash Flow1.94M6.60M-449.00K-5.50M-2.05M-2.81M
Investing Cash Flow-1.78M-768.00K570.00K-8.63M7.81M-636.00K
Financing Cash Flow-4.08M-4.29M-1.35M-2.92M-674.00K-1.22M

Xaar plc Technical Analysis

Technical Analysis Sentiment
Negative
Last Price104.00
Price Trends
50DMA
110.33
Negative
100DMA
118.39
Negative
200DMA
117.73
Negative
Market Momentum
MACD
0.26
Negative
RSI
50.43
Neutral
STOCH
58.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For GB:XAR, the sentiment is Negative. The current price of 104 is below the 20-day moving average (MA) of 107.77, below the 50-day MA of 110.33, and below the 200-day MA of 117.73, indicating a neutral trend. The MACD of 0.26 indicates Negative momentum. The RSI at 50.43 is Neutral, neither overbought nor oversold. The STOCH value of 58.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for GB:XAR.

Xaar plc Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
77
Outperform
£620.94M23.968.49%2.09%0.49%61.73%
74
Outperform
£2.75B32.789.15%2.12%3.15%-13.57%
70
Neutral
£85.23M18.959.34%7.36%31.93%
67
Neutral
£193.78M51.873.13%2.19%10.66%21.19%
61
Neutral
$37.18B12.37-10.20%1.83%8.50%-7.62%
56
Neutral
£85.99M-7.71-16.64%-7.35%-222.10%
39
Underperform
£43.85M-38.46-17.36%-14.81%-1362.50%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
GB:XAR
Xaar plc
110.00
29.00
35.80%
GB:GHH
Gooch & Housego
700.00
269.27
62.52%
GB:RSW
Renishaw
3,800.00
276.67
7.85%
GB:SDI
SDI Group
82.00
28.50
53.27%
GB:WPHO
Windar Photonics
44.50
-10.00
-18.35%
GB:DSCV
discoverIE Group plc
634.00
2.71
0.43%

Xaar plc Corporate Events

Business Operations and StrategyFinancial Disclosures
Xaar Lifts 2025 Revenue and Margins as New Inkjet Applications Gain Traction
Positive
Jan 14, 2026

Xaar reported a like-for-like revenue increase of 16.6% for 2025 to £60.3 million, driven by strong 28.9% growth in printhead sales and stable performance in its core ceramics segment, while newer products and markets such as jewellery wax provided additional momentum. Improved gross margins from higher volumes and cost control mean adjusted full-year profits are expected to be slightly ahead of expectations, though net cash declined to about £4.8 million after £3.1 million of capital investment; the company highlighted that its differentiated fluid-deposition technology is now contributing to revenues beyond ceramics and expressed optimism about the scale of future opportunities, bolstered by the appointment of Berenberg and Singer Capital Markets as joint corporate brokers.

The most recent analyst rating on (GB:XAR) stock is a Hold with a £105.00 price target. To see the full list of analyst forecasts on Xaar plc stock, see the GB:XAR Stock Forecast page.

Regulatory Filings and Compliance
Xaar Confirms Total Voting Rights at Year-End 2025
Neutral
Jan 5, 2026

Xaar plc has confirmed that its issued share capital comprises 79,816,895 ordinary shares of 10 pence each, with no shares held in treasury, establishing the total number of voting rights in the company as at 31 December 2025. The company noted that this figure, which includes shares held within trustee and ESOP structures, should be used by shareholders as the reference point for determining whether they are required to disclose holdings or changes in their interests under UK financial transparency rules, providing clarity for investors and regulators on Xaar’s capital and voting structure.

The most recent analyst rating on (GB:XAR) stock is a Hold with a £124.00 price target. To see the full list of analyst forecasts on Xaar plc stock, see the GB:XAR Stock Forecast page.

Regulatory Filings and Compliance
Xaar plc Announces Total Voting Rights Update
Neutral
Dec 1, 2025

Xaar plc announced that its issued share capital comprises 79,783,945 ordinary shares, with no shares held in treasury. This announcement is in accordance with the FCA’s Disclosure and Transparency Rules, and the total voting rights figure will be used by shareholders to assess their interests in the company.

The most recent analyst rating on (GB:XAR) stock is a Hold with a £116.00 price target. To see the full list of analyst forecasts on Xaar plc stock, see the GB:XAR Stock Forecast page.

Regulatory Filings and Compliance
Xaar plc Announces Lapse of Share Options by COO
Neutral
Nov 24, 2025

Xaar plc announced a transaction involving the lapse of share options under the Xaar 2017 Sharesave Plan by Graham Tweedale, the Chief Operating Officer and Person Discharging Managerial Responsibilities. This transaction, involving 3,857 shares at a price of £1.40 each, was conducted outside a trading venue and reflects the company’s adherence to the UK Market Abuse Regulation, ensuring transparency and regulatory compliance.

The most recent analyst rating on (GB:XAR) stock is a Hold with a £116.00 price target. To see the full list of analyst forecasts on Xaar plc stock, see the GB:XAR Stock Forecast page.

Regulatory Filings and Compliance
Xaar plc Announces Total Voting Rights Update
Neutral
Nov 3, 2025

Xaar plc has announced its total voting rights, with the company’s issued share capital consisting of 79,783,945 ordinary shares as of October 31, 2025. This figure is crucial for shareholders to determine their required notifications under the FCA’s Disclosure and Transparency Rules, impacting how stakeholders manage their interests in the company.

The most recent analyst rating on (GB:XAR) stock is a Hold with a £126.00 price target. To see the full list of analyst forecasts on Xaar plc stock, see the GB:XAR Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 07, 2025